- Home
- SPWH vs BTAI Comparison
SPWH vs BTAI Comparison
Compare SPWH & BTAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPWH
- BTAI
- Stock Information
- Founded
- SPWH 1986
- BTAI 2017
- Country
- SPWH United States
- BTAI United States
- Employees
- SPWH N/A
- BTAI N/A
- Industry
- SPWH Other Specialty Stores
- BTAI Biotechnology: Pharmaceutical Preparations
- Sector
- SPWH Consumer Discretionary
- BTAI Health Care
- Exchange
- SPWH Nasdaq
- BTAI Nasdaq
- Market Cap
- SPWH 68.9M
- BTAI 73.4M
- IPO Year
- SPWH 2014
- BTAI 2018
- Fundamental
- Price
- SPWH $2.91
- BTAI $4.98
- Analyst Decision
- SPWH Strong Buy
- BTAI Strong Buy
- Analyst Count
- SPWH 5
- BTAI 4
- Target Price
- SPWH $3.35
- BTAI $40.00
- AVG Volume (30 Days)
- SPWH 375.2K
- BTAI 25.3M
- Earning Date
- SPWH 09-02-2025
- BTAI 08-12-2025
- Dividend Yield
- SPWH N/A
- BTAI N/A
- EPS Growth
- SPWH N/A
- BTAI N/A
- EPS
- SPWH N/A
- BTAI N/A
- Revenue
- SPWH $1,202,496,000.00
- BTAI $868,000.00
- Revenue This Year
- SPWH $3.37
- BTAI N/A
- Revenue Next Year
- SPWH $1.94
- BTAI $328.13
- P/E Ratio
- SPWH N/A
- BTAI N/A
- Revenue Growth
- SPWH N/A
- BTAI N/A
- 52 Week Low
- SPWH $0.92
- BTAI $1.17
- 52 Week High
- SPWH $4.33
- BTAI $13.36
- Technical
- Relative Strength Index (RSI)
- SPWH 41.71
- BTAI 60.05
- Support Level
- SPWH $2.63
- BTAI $4.46
- Resistance Level
- SPWH $3.70
- BTAI $6.85
- Average True Range (ATR)
- SPWH 0.23
- BTAI 1.35
- MACD
- SPWH -0.06
- BTAI 0.02
- Stochastic Oscillator
- SPWH 26.17
- BTAI 46.74
About SPWH Sportsman's Warehouse Holdings Inc.
Sportsman's Warehouse Holdings Inc together with its subsidiaries operates as an outdoor sporting goods retailer. It provides a one-stop shopping experience that equips customers with the right quality, brand name hunting, shooting, fishing, and camping gear to maximize enjoyment of the outdoors. The company offers products in the categories of Camping, Apparel, Fishing, Footwear, Hunting and shooting, and Optics, Electronics, Accessories, and Other products. It provides products such as Backpacks, Jackets, Camp essentials, Hiking boots, GPS devices, ATV accessories and Fishing rods, among others.
About BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.